A practical guide to the use of anti-epileptic drugs by neurosurgeons

References

• Engel J Jr. ILAE classification of epilepsy syndromes. Epilepsy Res 2006;70 (Suppl 1):S5–S10.
   PubMed Web of Science ®Google Scholar
• Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1000–15.
   PubMed Web of Science ®Google Scholar
• Available from: http://www.sanad2.org.uk/summary
   Google Scholar
• Schierhout G, Roberts I. Anti-epileptic drugs for preventing seizures following acute traumatic brain injury. Cochrane Database Syst Rev 2000;2:CD000173.
   Google Scholar
• Szaflarski JP, Sangha KS, Lindsell CJ, Shutter LA. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care 2010;12:165–72.
   PubMed Web of Science ®Google Scholar
• Maschio M. Brain tumor-related epilepsy. Curr Neuropharmacol 2012;10:124–33.
   PubMed Web of Science ®Google Scholar
• Vecht CJ, Kerkhof M, Duran-Pena A. Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist 2014;19:751–9.
   PubMed Web of Science ®Google Scholar
• Tremont-Lukats IW, Ratilal BO, Armstrong T, Gilbert MR. Antiepileptic drugs for preventing seizures in people with brain tumors. Cochrane Database Syst Rev 2008;2:CD004424.
   Google Scholar
• Komotar RJ, Raper DM, Strake RM, Lorgulescu JB, Gutin PH. Prophylactic antiepileptic drug therapy in patients undergoing suptratentorial meningioma resection: a systematic analysis of efficacy. J Neurosurgery 2011;115: 483–90.
   PubMed Web of Science ®Google Scholar
• Weston J, Greenhalgh J, Marson AG. Antiepileptic drugs as prophylaxis for post-craniotomy seizures. Cochrane Database Syst Rev 2015;3:CD007286.
   Google Scholar
• Lin CL, Dumont AS, Lieu AS, et al. Characterization of perioperative seizures and epilepsy following aneurysmal subarachnoid hemorrhage. J Neurosurg 2003;99:978–85.
   PubMed Web of Science ®Google Scholar
• Marigold R, Gunther A, Tiwari D, Kwan J. Antiepileptic drugs for the primary and secondary prevention of seizues after subarachnoid haemorrhage. Cochrane Database Syst Rev 2013;5:CD008710.
   Google Scholar
• Bederson JB, Sander Connolly E Jr, Hunt Batjer H, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke 2009;40:994–1025.
   PubMed Web of Science ®Google Scholar
• Hakan T, Ceran N, Erdem I, Berkman MZ, Göktaş P. Bacterial brain abscesses: an evaluation of 96 cases. J Infect 2006;52:359–66.
   PubMed Web of Science ®Google Scholar
• Osenbach RK, Loftus CM. Diagnosis and management of brain abscess. Neurosurg Clin N Am 1992;3:403–20.
   PubMedGoogle Scholar
• Muzumdar D, Jhawar S, Goel A. Brain abscess: an overview. Int J Surg 2011;9:136–44.
   PubMed Web of Science ®Google Scholar
• Kerrigan S, Grant R. Antiepileptic drugs for treating seizures in adults with brain tumours. Cochrane Database Syst Rev 2011;8:CD008586.
   Google Scholar
• Maschio M, Albani F, Baruzzi, et al. Levetiracetam therapy in patients with brain tumour and epilepsy. J Neurooncol 2006;80:97–100.
   PubMed Web of Science ®Google Scholar
• Rossetti AO, Jeckelmann S, Novy J, Roth P, Weller M, Stupp R. Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study. Neuro-oncology 2014;16:584–8.
   PubMed Web of Science ®Google Scholar
• Weller M, Gorlia T, Cairncross JG, et al. Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma. Neurology 2011;77:1156–64.
   PubMed Web of Science ®Google Scholar
• Das RR, Artsy E, Hurwitz S, et al. Outcomes after discontinuation of antiepileptic drugs after surgery in patients with low grade brain tumors and meningiomas. J Neurooncol 2012;107:565–70.
   PubMed Web of Science ®Google Scholar
• Brophy GM, Bell R, Claassen J, Neurocritical Care Society Status Epilepticus Guideline Writing Committee, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012;17:3–23.
   PubMed Web of Science ®Google Scholar
• Jenssen S, Gracely EJ, Sperling MR. How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit. Epilepsia 2006;47:1499–503.
   PubMed Web of Science ®Google Scholar
• Silbergleit R, Lowenstein D, Durkalski V, Conwit R. Neurological Emergency Treatment Trials (NETT) Investigators. RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): a double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics. Epilepsia 2011;52(Suppl 8):45–7.
   PubMed Web of Science ®Google Scholar
• Rossetti AO. Which anesthetic should be used in the treatment of refractory status epilepticus? Epilepsia 2007;48(Suppl 8):52–5.
   PubMed Web of Science ®Google Scholar
• Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 2011;134:2802–18.
   PubMed Web of Science ®Google Scholar
• Valentín A, Nguyen HQ, Skupenova AM, et al. Centromedian thalamic nuclei deep brain stimulation in refractory status epilepticus. Brain Stimul 2012;5:594–8.
   PubMed Web of Science ®Google Scholar
• Kimford J, Meador KJ, Loring DW. Developmental effects of antiepileptic drugs and the need for improved regulations. Neurology 2016;86:297–306.
   PubMed Web of Science ®Google Scholar
• Lagana AS, Triolo O, D’Amico V, et al. Management of women with epilepsy: from preconception to post-partum. Arch Gynecol Obstet 2016;293:493–503.
   PubMed Web of Science ®Google Scholar
• Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193–8.
   PubMed Web of Science ®Google Scholar
• Tomson T, Battino D, Bonizzoni, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609–17.
   PubMed Web of Science ®Google Scholar
• Crawford P. Best practice guidelines for the management of women with epilepsy. Epilepsia 2005;46: 117–24.
   PubMed Web of Science ®Google Scholar
• Montouris G, Abou-Khalil B. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent? Epilepsia 2009;50:16–20.
   PubMed Web of Science ®Google Scholar
• Lamberts RJ, Thijs RD, Laffan A, Langan Y, Sander JW. Sudden unexpected death in epilepsy: people with nocturnal seizures may be at highest risk. Epilepsia 2012;53:253–7.
   PubMed Web of Science ®Google Scholar
• Shankar R, Cox D, Jalihal V, Brown S, Hanna J, Mclean B. Sudden unexpected death in epilepsy (SUDEP): development of a safety checklist. Seizure 2013;22:812–7.
   PubMed Web of Science ®Google Scholar